Program Overview

Micrographic Surgery and Dermatologic Oncology Fellowship

Overview

The Micrographic Surgery and Dermatologic Oncology Fellowship Program at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center Campus is a one-year program accredited by the Accreditation Council for Graduate Medical Education (ACGME). It provides a comprehensive experience in the clinical aspects of Micrographic Surgery and Dermatologic Oncology and the opportunity to pursue intensive training in an academic setting.

Program Details

• The Fellowship Program is designed for physicians who aspire to a career in academic Dermatologic Surgery.
• It emphasizes those elements of the discipline relevant to this career goal.
• Fellows who successfully complete the program are eligible for board certification in micrographic surgery and dermatologic oncology, as per the American Board of Medical Specialties (ABMS).

Leadership

• The program is directed by Faramarz Samie, MD, PhD, Director of the Micrographic Surgery and Dermatologic Oncology Fellowship Program.

Program Structure

• The program offers advanced training and research opportunities in Micrographic Surgery and Dermatologic Oncology.
• It is a comprehensive experience that includes clinical aspects and academic training.

Career Opportunities

• The program is designed for physicians who aspire to a career in academic Dermatologic Surgery.
• It provides the necessary training and experience for a successful career in this field.

Accreditation

• The program is accredited by the Accreditation Council for Graduate Medical Education (ACGME).
• It meets the standards and requirements for a one-year fellowship program in Micrographic Surgery and Dermatologic Oncology.

Eligibility

• The program is open to physicians who have completed their residency training in dermatology or a related field.
• Applicants must meet the eligibility requirements set by the American Board of Medical Specialties (ABMS) for board certification in micrographic surgery and dermatologic oncology.